Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...
The U.S. trade deficit in goods widened to a record high in December, likely as businesses front-loaded imports of industrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback